Our Portfolio

Explore our growing portfolio of groundbreaking companies advancing medical countermeasures for children. From life-saving diagnostics and therapeutics to next-generation devices and vaccines, these innovators are tackling urgent pediatric health security needs for a stronger, more resilient future for our children.

Stealth Startup

Stealth Startup

This company is developing a regenerative biologic medical countermeasure for cutaneous radiation injury, a serious consequence of nuclear mass-casualty events. Built on a tissue-derived extracellular matrix platform, the therapy targets the biological cascade driving radiation-related tissue damage and is advancing toward preclinical large-animal studies and a potential BLA pathway.